CSF2 and arthritic joint disease: In our study, we found an expanded population of peripheral T cells expressing GM-CSF in untreated patients with active RA compared to disease controls with inflammatory (PsA) or non-inflammatory (osteoarthritis) arthritis as well as to patients with systemic rheumatic diseases (vasculitis, Sjogren’s syndrome, myositis).